Jun. 29 at 4:36 PM
$NEUP Just getting back from Vegas and doing reviewing this. Still not completely up to speed but a few things I noticed and can comment my opinion on.
1). Why this random British company that has no focus in CNS / Neuro? There are dozens upon dozens of private companies out there looking to RM in the US. Would have been a lot easier and quicker.
$PASG and a few others just did RMs and it only took them 3 months. But they did not have valuable assets to deal with. So why the British company? Is there some connection w/ the CEO and the MK-1167 asset? Or something else going on ?
2). This is already trading on GBX exchange under ticker
$SCLP. This is unique because we are able to see the market cap is 250M USD. Likely in a RM, they will get additional funding throuhg PIPE and the valuation may be higher ...say 300-400M USD. We are sitting at 25M market cap right now so we need to get a % that would equate to 25M just to break even. So likely upper single digits...
